Never Before Exposed: Borassus Flabellifer’s Shadow on Liver Health

Authors

  • Harshil Gadhiya Department of Pharmacology, School of Pharmacy, RK University, Rajkot-360020, Gujarat, India
  • Riddhi Shingala Department of Pharmacology, School of Pharmacy, RK University, Rajkot-360020, Gujarat, India
  • Dhirangi Gajipara Department of Pharmacology, School of Pharmacy, RK University, Rajkot-360020, Gujarat, India
  • Yash Radhanpura Department of Pharmacology, School of Pharmacy, RK University, Rajkot-360020, Gujarat, India
  • Pravin Tirgar Department of Pharmacology, School of Pharmacy, RK University, Rajkot-360020, Gujarat, India

DOI:

https://doi.org/10.25004/IJPSDR.2024.160223

Keywords:

Liver cirrhosis, Liver Encephalopathy, Borassus Flabellifer, Palm Tree

Abstract

The last stage of many hepatic diseases, including hepatitis, is cirrhosis. The liver's vital function in detoxifying xenobiotics—such as medications and toxic composites—is the subject of much research. Liver cirrhosis is the cause of alterations in the liver's architecture that mostly affect protein binding, blood circulation, and the enzymes that break down medicinal substances. The main reason why therapeutic metabolising enzymes disappear is because to liver towel loss. However, not all enzyme activity is decreased in tandem; some are only changed in one specific case. This case report focuses on the clinical features, diagnostic evaluation, and therapeutic concerns of a patient having liver cirrhosis. Further research and advancements in our comprehension of the pathogenesis and treatment of cirrhosis are necessary in order to enhance outcomes and minimise the burden of this illness on those who are impacted.

Downloads

Download data is not yet available.

References

Elbekai RH, Korashy HM, El-Kadi AO. The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes. Current drug metabolism. 2004 Apr 1;5(2):157-67. Available from: doi.org/10.2174/1389200043489054

Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. The Lancet. 2014 May 17;383(9930):1749-61. Available from: doi.org/10.1016/ S0140-6736(14)60121-5

Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. The Lancet. 2021 Oct 9;398(10308):1359-76. Available from: doi.org/10.1016/S0140-6736(21)01374-X

Ardizzone G, Arrigo A, Schellino MM, Stratta C, Valzan S, Skurzak S, Andruetto P, Panio A, Ballaris MA, Lavezzo B, Salizzoni M. Neurological complications of liver cirrhosis and orthotopic liver transplant. InTransplantation proceedings 2006 Apr 1 (Vol. 38, No. 3, pp. 789-792). Elsevier. Available from: doi.org/10.1016/j. transproceed.2006.01.039

Jerry A. A comprehensive review on the medicinal properties of Borassus flabellifer. Journal of Academia and Industrial Research. 2018 Dec;7(7):93-7.

Krishnaveni TR, Arunachalam R, Chandrakumar M, Parthasarathi G, Nisha R. Potential review on palmyra (Borassus flabellifer L.). Advances in Research. 2020 Aug 4;21(9):29-40. Available from: doi. org/10.9734/air/2020/v21i930229

Poordad FF. Presentation and complications associated with cirrhosis of the liver. Current medical research and opinion. 2015 May 4;31(5):925-37. Available from: doi.org/10.1185/03007995. 2015.1021905

Prieto O JE, Sánchez P S, Prieto O RG, Rojas D EL, González L, Mendivelso F. Clinical Characteristics and Decompensation in Patients with Liver Cirrhosis Treated at Two Hepatology Centers in Bogota DC from 2010 To 2014. Revista colombiana de Gastroenterología. 2016 Jan;31(1):1-8. Available from: doi. org/10.22516/25007440.66

Ge PS, Runyon BA. Treatment of patients with cirrhosis. New England Journal of Medicine. 2016 Aug 25;375(8):767-77 Available from: doi.org/10.1056/nejmra1504367

Downloads

Published

30-03-2024

Issue

Section

Case Study

How to Cite

“Never Before Exposed: Borassus Flabellifer’s Shadow on Liver Health”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 16, no. 2, Mar. 2024, pp. 299-01, https://doi.org/10.25004/IJPSDR.2024.160223.